![](https://webarchive.library.unt.edu/eot2008/20090514060459im_/http://www.cancer.gov/images/spacer.gif) |
|
(BEH-loh-TEE-kun HY-droh-KLOR-ide)
![](https://webarchive.library.unt.edu/eot2008/20090514060459im_/http://www.cancer.gov/images/spacer.gif)
| A substance being studied in the treatment of small cell lung cancer and other types of cancer. It blocks certain enzymes needed for cell division and DNA repair, and it may kill cancer cells. It is a type of camptothecin analog and a type of topoisomerase inhibitor. |
Previous Definitions: | beclomethasone, behavior modification, belinostat, Bellini duct carcinoma, belotecan | Next Definitions: | Bence Jones protein, bench-to-bedside, bendamustine, bendamustine hydrochloride, benign |
|
![](https://webarchive.library.unt.edu/eot2008/20090514060459im_/http://www.cancer.gov/images/spacer.gif) |